$32.53
-0.85-2.55%
Last update: Nov 5, 5:47 PM
Maze Therapeutics Inc
MAZENASDAQ
Maze Therapeutics (MAZE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.71 | $-0.59 | $-0.71 | $-0.71 |
| Actual | $-0.76 | $-0.45 | $-0.65 | $-0.66 |
| Surprise | -7.04% | +23.7% | +8.45% | +7.04% |
| Revenue | ||||
| Estimate | $1.8M | $10.1M | — | $2.1M |
| Actual | $0 | $20.0M | $0 | $0 |
| Surprise | -100.0% | +99.0% | — | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.76 | $-0.79 | $-0.72 | $-0.72 |
| Revenue | ||||
| Consensus | $1.0M | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.76 | $-0.71 | -7.04 % |
| Q1 | May 12, 2026 | $-0.45 | $-0.59 | 23.7 % |
| Q4 | Mar 25, 2026 | $-0.65 | $-0.71 | 8.45 % |
| Q3 | Nov 6, 2025 | $-0.66 | $-0.71 | 7.04 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $0 | $1.82M | -100.0 % |
| Q1 | May 12, 2026 | $20.00M | $10.05M | 99.0 % |
| Q3 | Nov 6, 2025 | $0 | $2.08M | -100.0 % |
| Q2 | Aug 12, 2025 | $0 | $6.25M | -100.0 % |
